GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease

GLIA

Volumn 63, Issue 6, 2015, Pages 1036-1056

  Kamphuis, Willem ^a   Kooijman, Lieneke ^a,b   Orre, Marie ^c   Stassen, Oscar ^a   Pekny, Milos ^d,e,f   Hol, Elly M ^a,b,g  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^f UNIVERSITY OF NEWCASTLE   (Australia)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Astrocytes; A ; Gene expression; GFAP; Gliosis; Microarray; Microglia; Vimentin

Indexed keywords

AQUAPORIN 4 ANTIBODY; CATHEPSIN; CONNEXIN 47; TRANSCRIPTOME; AMYLOID PRECURSOR PROTEIN; APP PROTEIN, HUMAN; CXCL5 PROTEIN, HUMAN; CXCL5 PROTEIN, MOUSE; ENHANCED GREEN FLUORESCENT PROTEIN; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEIN; PRESENILIN 1; PSEN1 PROTEIN, HUMAN; VIMENTIN;

ADULT; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; EXPERIMENTAL MODEL; FEMALE; GENE; GENE EXPRESSION; GLIA; GLIAL FIBRILLARY ACIDIC PROTEIN DEFICIENCY; INFLAMMATION; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; VIMENTIN DEFICIENCY; WILD TYPE; 129 MOUSE; AGED; ANIMAL; BRAIN; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ASTROCYTES; BRAIN; CELL PROLIFERATION; CHEMOKINE CXCL5; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEINS; HUMANS; MALE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; PRESENILIN-1; VIMENTIN;

EID: 84927962117     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22800     Document Type: Article

References (72)

1. Anderson MA, Ao Y, Sofroniew MV. 2013. Heterogeneity of reactive astrocytes. Neurosci Lett 565:23-29.
2. Bossers K, Ylstra B, Brakenhoff RH, Smeets SJ, Verhaagen J, van de Wiel MA. 2010. Intensity-based analysis of dual-color gene expression data as an alternative to ratio-based analysis to enhance reproducibility. BMC Genomics 11:112.
3. Brenner M. 2014. Role of GFAP in CNS injuries. Neurosci Lett 565:7-13.
4. Di Castro MA, Chuquet J, Liaudet N, Bhaukaurally K, Santello M, Bouvier D, Tiret P, Volterra A. 2011. Local Ca(2+) detection and modulation of synaptic release by astrocytes. Nat Neurosci 14:1276-1284.
5. Ding M, Eliasson C, Betsholtz C, Hamberger A, Pekny M. 1998. Altered taurine release following hypotonic stress in astrocytes from mice deficient for GFAP and vimentin. Brain Res Mol Brain Res 62:77-81.
6. Eliasson C, Sahlgren C, Berthold CH, Stakeberg J, Celis JE, Betsholtz C, Eriksson JE, Pekny M. 1999. Intermediate filament protein partnership in astrocytes. J Biol Chem 274:23996-24006.
7. Elobeid A, Bongcam-Rudloff E, Westermark B, Nister M. 2000. Effects of inducible glial fibrillary acidic protein on glioma cell motility and proliferation. J Neurosci Res 60:245-256.
8. Furman JL, Sama DM, Gant JC, Beckett TL, Murphy MP, Bachstetter AD, Van Eldik LJ, Norris CM. 2012. Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer's disease. J Neurosci 32:16129-16140.
9. Gimenez YR, Langa F, Menet V, Privat A. 2000. Comparative anatomy of the cerebellar cortex in mice lacking vimentin, GFAP, and both vimentin and GFAP. GLIA 31:69-83.
10. Glazner KA, Odero GL, Anema E, Motnenko A, Schapansky J, Grossman D, Oliver DR, Glazner GW, Albensi, BC. 2010. Strain specific differences in memory and neuropathology in a mouse model of Alzheimer's disease. Life Sci 86:942-950.
11. Halassa MM, Haydon PG. 2010. Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annu Rev Physiol 72:335-355.
12. Herrmann JE, Imura T, Song B, Qi J, Ao Y, Nguyen TK, Korsak RA, Takeda K, Akira S, Sofroniew MV. 2008. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci 28:7231-7243.
13. Hughes EG, Maguire JL, McMinn MT, Scholz RE, Sutherland ML. 2004. Loss of glial fibrillary acidic protein results in decreased glutamate transport and inhibition of PKA-induced EAAT2 cell surface trafficking. Brain Res Mol Brain Res 124:114-123.
14. Jankowsky JL, Slunt HH, Gonzales V, Jenkins NA, Copeland NG, Borchelt DR. 2004. APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1. Neurobiol Aging 25:885-892.
15. Jo S, Yarishkin O, Hwang YJ, Chun YE, Park M, Woo DH, Bae JY, Kim T, Lee J, Chun H, Park HJ, Lee DY, Hong J, Kim HY, Oh SJ, Park SJ, Lee H, Yoon BE, Kim Y, Jeong Y, Shim I, Bae YC, Cho J, Kowall NW, Ryu H, Hwang E, Kim D, Lee CJ. 2014. GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease. Nat Med 20:886-896.
16. Kamphuis W, Mamber C, Moeton M, Kooijman L, Sluijs JA, Jansen AH, Verveer M, de Groot LR, Smith VD, Rangarajan S, Rodriguez JJ, Orre M, Hol EM. 2012a. GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease. PLoS One 7:e42823.
17. Kamphuis W, Orre M, Kooijman L, Dahmen M, Hol EM. 2012b. Differential cell proliferation in the cortex of the APPswePS1dE9 Alzheimer's disease mouse model. GLIA 60:615-629.
18. Kamphuis W, Middeldorp J, Kooijman L, Sluijs JA, Kooi EJ, Moeton M, Freriks M, Mizee MR, Hol EM. 2014. Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease. Neurobiol Aging 35:492-510.
19. Kato S, Gondo T, Hoshii Y, Takahashi M, Yamada M, Ishihara T. 1998. Confocal observation of senile plaques in Alzheimer's disease: Senile plaque morphology and relationship between senile plaques and astrocytes. Pathol Int 48:332-340.
20. Kim S, Coulombe PA. 2010. Emerging role for the cytoskeleton as an organizer and regulator of translation. Nat Rev Mol Cell Biol 11:75-81.
21. Kimelberg HK, Nedergaard M. 2010. Functions of astrocytes and their potential as therapeutic targets. Neurotherapeutics 7:338-353.
22. Kinouchi R, Takeda M, Yang L, Wilhelmsson U, Lundkvist A, Pekny M, Chen DF. 2003. Robust neural integration from retinal transplants in mice deficient in GFAP and vimentin. Nat Neurosci 6:863-868.
23. Kraft AW, Hu X, Yoon H, Yan P, Xiao Q, Wang Y, Gil SC, Brown J, Wilhelmsson U, Restivo JL, Cirrito JR, Holtzman DM, Kim J, Pekny M, Lee JM. 2013. Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice. FASEB J 27:198.
24. Kuchibhotla KV, Lattarulo CR, Hyman BT, Bacskai BJ. 2009. Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science 323:1211-1215.
25. Lee HU, Yamazaki Y, Tanaka KF, Furuya K, Sokabe M, Hida H, Takao K, Miyakawa T, Fujii S, Ikenaka K. 2012. Increased astrocytic ATP release results in enhanced excitability of the hippocampus. GLIA 61:210-224.
26. Lepekhin EA, Eliasson C, Berthold CH, Berezin V, Bock E, Pekny M. 2001. Intermediate filaments regulate astrocyte motility. J Neurochem 79:617-625.
27. Li L, Lundkvist A, Andersson D, Wilhelmsson U, Nagai N, Pardo AC, Nodin C, Stahlberg A, Aprico K, Larsson K, Yabe T, Moons L, Fotheringham A, Davies I, Carmeliet P, Schwartz JP, Pekna M, Kubista M, Blomstrand F, Maragakis N, Nilsson M, Pekny M. 2008. Protective role of reactive astrocytes in brain ischemia. J Cereb Blood Flow Metab 28:468-481.
28. Lu YB, Iandiev I, Hollborn M, Korber N, Ulbricht E, Hirrlinger PG, Pannicke T, Wei EQ, Bringmann A, Wolburg H, Wilhelmsson U, Pekny M, Wiedemann P, Reichenbach A, Kas, JA. 2011. Reactive glial cells: Increased stiffness correlates with increased intermediate filament expression. FASEB J 25:624-631.
29. McCall MA, Gregg RG, Behringer RR, Brenner M, Delaney CL, Galbreath EJ, Zhang CL, Pearce RA, Chiu SY, Messing A. 1996. Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. Proc Natl Acad Sci USA 93:6361-6366.
30. Menet V, Ribotta M, Chauvet N, Drian MJ, Lannoy J, Colucci-Guyon E, Privat A. 2001. Inactivation of the glial fibrillary acidic protein gene, but not that of vimentin, improves neuronal survival and neurite growth by modifying adhesion molecule expression. J Neurosci 21:6147-6158.
31. Menet V, Prieto, M, Privat A, Ribotta M. 2003. Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes. Proc Natl Acad Sci USA 100:8999-9004.
32. Meraz-Rios MA, Toral-Rios D, Franco-Bocanegra D, Villeda-Hernandez J, Campos-Pena V. 2013. Inflammatory process in Alzheimer's Disease. Front Integr Neurosci 7:59.
33. Moeton M, Kanski R, Stassen OM, Sluijs JA, Geerts D, Van Tijn P, Wiche G, Van Strien ME, Hol EM. 2014. Silencing GFAP isoforms in astrocytoma cells disturbs laminin-dependent motility and cell adhesion. FASEB J 28:2942-2954.
34. Nakazawa T, Takeda M, Lewis GP, Cho KS, Jiao J, Wilhelmsson U, Fisher SK, Pekny M, Chen DF, Miller JW. 2007. Attenuated glial reactions and photoreceptor degeneration after retinal detachment in mice deficient in glial fibrillary acidic protein and vimentin. Invest Ophthalmol Vis Sci 48:2760-2768.
35. Nawashiro H, Messing A, Azzam N, Brenner M. 1998. Mice lacking GFAP are hypersensitive to traumatic cerebrospinal injury. Neuroreport 9:1691-1696.
36. Nawashiro H, Brenner M, Fukui S, Shima K, Hallenbeck JM. 2000. High susceptibility to cerebral ischemia in GFAP-null mice. J Cereb Blood Flow Metab 20:1040-1044.
37. Nolte C, Matyash M, Pivneva T, Schipke CG, Ohlemeyer C, Hanisch UK, Kirchhoff F, Kettenmann H. 2001. GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue. GLIA 33:72-86.
38. Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K, Yamane J, Yoshimura A, Iwamoto Y, Toyama Y, Okano H. 2006. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 12:829-834.
39. Orre M, Kamphuis W, Osborn LM, Jansen AH, Kooijman L, Bossers K, Hol EM. 2014a. Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction. Neurobiol Aging 35:2746-2760.
40. Orre M, Kamphuis, W Osborn LM, Melief J, Kooijman L, Huitinga I, Klooster J, Bossers K, Hol EM. 2014b. Acute isolation and transcriptome characterization of cortical astrocytes and microglia from young and aged mice. Neurobiol Aging 35:1-14.
41. Otani N, Nawashiro H, Fukui S, Ooigawa H, Ohsumi A, Toyooka T, Shima K, Gomi H, Brenner M. 2006. Enhanced hippocampal neurodegeneration after traumatic or kainate excitotoxicity in GFAP-null mice. J Clin Neurosci 13:934-938.
42. Pallari HM, Eriksson JE. 2006. Intermediate filaments as signaling platforms. Sci STKE 2006:e53.
43. Panatier A, Vallee J, Haber M, Murai KK, Lacaille JC, Robitaille R. 2011. Astrocytes are endogenous regulators of basal transmission at central synapses. Cell 146:785-798.
44. Pang Y, Cai Z, Rhodes PG. 2001. Analysis of genes differentially expressed in astrocytes stimulated with lipopolysaccharide using cDNA arrays. Brain Res 914:15-22.
45. Pekny M, Pekna M. 2014. Astrocyte reactivity and reactive astrogliosis: The costs and benefits. Physiol Rev. 94, 1077-1098.
46. Pekny M, Leveen P, Pekna M, Eliasson C, Berthold CH, Westermark B, Betsholtz C. 1995. Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally. EMBO J 14:1590-1598.
47. Pekny M, Eliasson C, Chien CL, Kindblom LG, Liem R, Hamberger A, Betsholtz C. 1998a. GFAP-deficient astrocytes are capable of stellation in vitro when cocultured with neurons and exhibit a reduced amount of intermediate filaments and an increased cell saturation density. Exp Cell Res 239:332-343.
48. Pekny M, Stanness KA, Eliasson C, Betsholtz C, Janigro D. 1998b. Impaired induction of blood-brain barrier properties in aortic endothelial cells by astrocytes from GFAP-deficient mice. GLIA 22:390-400.
49. Pekny M, Johansson CB, Eliasson C, Stakeberg J, Wallen A, Perlmann T, Lendahl U, Betsholtz C, Berthold CH, Frisen J. 1999. Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin. J Cell Biol 145:503-514.
50. Pekny M, Wilhelmsson U, Pekna M. 2014. The dual role of astrocyte activation and reactive gliosis. Neurosci Lett 565:30-38.
51. Peters O, Schipke CG, Philipps A, Haas B, Pannasch U, Wang LP, Benedetti B, Kingston AE, Kettenmann H. 2009. Astrocyte function is modified by Alzheimer's disease-like pathology in aged mice. J Alzheimers Dis 18:177-189.
52. Potokar M, Kreft M, Li L, Daniel AJ, Pangrsic T, Chowdhury HH, Pekny M, Zorec R. 2007. Cytoskeleton and vesicle mobility in astrocytes. Traffic 8:12-20.
53. Potokar M, Stenovec M, Gabrijel M, Li L, Kreft M, Grilc S, Pekny M, Zorec R. 2010. Intermediate filaments attenuate stimulation-dependent mobility of endosomes/lysosomes in astrocytes. GLIA 58:1208-1219.
54. Roelofs RF, Fischer DF, Houtman SH, Sluijs JA, Van Haren W, van Leeuwen FW, Hol EM. 2005. Adult human subventricular, subgranular, and subpial zones contain astrocytes with a specialized intermediate filament cytoskeleton. GLIA 52:289-300.
55. Rustay NR, Cronin EA, Curzon P, Markosyan S, Bitner RS, Ellis TA, Waring JF, Decker MW, Rueter LE, Browman KE. 2010. Mice expressing the Swedish APP mutation on a 129 genetic background demonstrate consistent behavioral deficits and pathological markers of Alzheimer's disease. Brain Res 1311:136-147.
56. Schwab C, McGeer PL. 2008. Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J Alzheimers Dis 13:359-369.
57. Sebollela A, Freitas-Correa L, Oliveira FF, Paula-Lima AC, Saraiva LM, Martins SM, Mota LD, Torres C, Alves-Leon S, de Souza JM, Carraro DM, Brentani H, De Felice FG, Ferreira ST. 2012. Amyloid-beta oligomers induce differential gene expression in adult human brain slices. J Biol Chem 287:7436-7445.
58. Shibuki K, Gomi H, Chen L, Bao S, Kim JJ, Wakatsuki H, Fujisaki T, Fujimoto K, Katoh A, Ikeda T, Chen C, Thompson RF, Itohara S. 1996. Deficient cerebellar long-term depression, impaired eyeblink conditioning, and normal motor coordination in GFAP mutant mice. Neuron 16:587-599.
59. Simpson JE, Ince PG, Lace G, Forster G, Shaw PJ, Matthews F, Savva G, Brayne C, Wharton SB. 2010. Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol Aging 31:578-590.
60. Sofroniew MV, Vinters HV. 2010. Astrocytes: biology and pathology. Acta Neuropathol 119:7-35.
61. Stobart JL, Anderson CM. 2013. Multifunctional role of astrocytes as gatekeepers of neuronal energy supply. Front Cell Neurosci 7:38.
62. Vardjan N, Gabrijel M, Potokar M, Svajger U, Kreft M, Jeras M, de Pablo Y, Faiz M, Pekny M, Zorec R. 2012. IFN-gamma-induced increase in the mobility of MHC class II compartments in astrocytes depends on intermediate filaments. J Neuroinflammation 9:144.
63. Vincent AJ, Gasperini R, Foa L, Small DH. 2010. Astrocytes in Alzheimer's disease: Emerging roles in calcium dysregulation and synaptic plasticity. J Alzheimers Dis 22:699-714.
64. Wang X, Chen Y, Wang X, Lu, L. 2010. Genetic regulatory network analysis for app based on genetical genomics approach. Exp Aging Res 36:79-93.
65. Widestrand A, Faijerson J, Wilhelmsson U, Smith PL, Li L, Sihlbom C, Eriksson PS, Pekny M. 2007. Increased neurogenesis and astrogenesis from neural progenitor cells grafted in the hippocampus of GFAP-/-Vim-/- mice. Stem Cells 25:2619-2627.
66. Wilhelmsson U, Li L, Pekna M, Berthold CH, Blom S, Eliasson C, Renner O, Bushong E, Ellisman M, Morgan TE, Pekny M. 2004. Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration. J Neurosci 24:5016-5021.
67. Wirz KT, Bossers K, Stargardt A, Kamphuis W, Swaab DF, Hol EM, Verhaagen J. 2013. Cortical beta amyloid protein triggers an immune response, but no synaptic changes in the APPswe/PS1dE9 Alzheimer's disease mouse model. Neurobiol Aging 34:1328-1342.
68. Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F, Silverstein SC, Husemann J. 2003. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med 9:453-457.
69. Xiao Q, Yan P, Ma X, Liu H, Perez R, Zhu A, Gonzales E, Burchett JM, Schuler DR, Cirrito JR, Diwan A, Lee JM. 2014. Enhancing astrocytic lysosome biogenesis facilitates abeta clearance and attenuates amyloid plaque pathogenesis. J Neurosci 34:9607-9620.
70. Xu K, Malouf AT, Messing A, Silver J. 1999. Glial fibrillary acidic protein is necessary for mature astrocytes to react to beta-amyloid. GLIA 25:390-403.
71. Yang CN, Shiao YJ, Shie FS, Guo BS, Chen PH, Cho CY, Chen YJ, Huang FL, Tsay HJ. 2011. Mechanism mediating oligomeric Abeta clearance by naive primary microglia. Neurobiol Dis 42:221-230.
72. Yoshida T, Tomozawa Y, Arisato T, Okamoto Y, Hirano H, Nakagawa M. 2007. The functional alteration of mutant GFAP depends on the location of the domain: morphological and functional studies using astrocytoma-derived cells. J Hum Genet 52:362-369.